Overview
Introduction
This analysis examines the market position and future outlook for Daiichi. The profile
encompasses global and US specific company strategy, portfolio and pipeline analysis and assessment
of financial performance, with US, rest of world and global forecasts for key drugs to 2010. An
interactive forecasting and analysis tool provides continually updated quantitative and qualitative
information
Reasons to Purchase
- Understand how the proposed merger with Sankyo will impact Daiichis operations in the future
- Learn how Daiichis sales have been impacted by economic conditions in the Japanese market and
increasing competition from foreign companies
- Benchmark Daiichis performance against key rivals in the ethical pharmaceutical sector
| 
View Cart
